Wipro, Indian Overseas Bank and Aditya Vision to see some action today

Wipro has strengthened its alliance with Citrix Systems, Inc. and Hewlett Packard Enterprise (HPE). The partnership will provide enterprises a robust solution that will accelerate remote working and bring modernization into workspaces.

Indian Overseas Bank (IOB) has announced the launch of Retail Loans (home loan, personal loan & clean loan) on digital platform. The loans are now available through various channels, i.e. the bank website (www.iob. in), Internet Banking and the Mobile Banking App. IOB customers may apply for these loans through the bank website, mobile banking and internet banking, while non-customers may apply only through the bank website.

Aditya Vision has opened 3 new stores in Bihar. The company has opened its 65th Showroom at Patna, 66th Showroom at Banka and 67th Showroom at Barbigha in the state of Bihar.

Manappuram Finance is considering various options for raising funds through borrowings including by the way of issuance of various debt securities in onshore / offshore securities market by Public Issue, on Private Placement Basis or through issuing Commercial Papers. Based on the prevailing market conditions, the Board of Directors / Financial Resources and Management Committee / Debenture Committee of the Board of Directors of the Company may consider and approve issuances of Debt Securities during the month of May, 2021, subject to such terms and conditions including the issue price of debt securities, as the Board / respective Committee may deem fit.

Route Mobile has entered into a Share Purchase Agreement (SPA) with the existing promoters and shareholders to acquire 100% of the equity share capital of Phonon Communications (PCPL). The acquisition will be effective subject to the fulfilment of various terms and conditions as specified in the SPA.

Hindustan Unilever has reported results for fourth quarter ended March 31, 2021. The company has reported a rise of 41.08% in its net profit at Rs 2143 crore for the quarter under review as compared to Rs 1519 crore for the same quarter in the previous year. Total income of the company increased by 31.95% at Rs 12241 crore for Q4FY21 as compared Rs 9277 crore for the corresponding quarter previous year. On the consolidated basis, the company has reported a rise of 44.29% in its net profit attributed to the owners at Rs 2186 crore for the quarter under review as compared to Rs 1515 crore for the same quarter in the previous year. Total income of the company increased by 32.37% at Rs 12542 crore for Q4FY21 as compared Rs 9475 crore for the corresponding quarter previous year.

Dr. Reddy's Laboratories along with its subsidiaries announced the launch of Albendazole Tablets, USP, a therapeutic equivalent generic version of Albenza Tablets, 200 mg, approved by the US Food and Drug Administration (USFDA). The Albenza brand and generic had U.S. sales of approximately $27 million MAT for the most recent twelve months ending in November 2020 according to IQVIA Health.